Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Compliance News | November 11, 2025 The administration, together with pharmaceutical manufacturers Eli Lilly and Novo Nordisk, announced an agreement to lower prices and expand access to glucagon-like peptide-1 receptor agonists (GLP-1s) for weight loss for those in the Medicare Part D and Medicaid programs as well as direct-to-consumer (DTC) purchasing
Get started Schedule an assessment with Protocol Health to review your goals, symptoms, and options with a provider
Simple, transparent careno subscriptions, no hidden fees
What this means in practice: If you are on a GLP-1 and oral estradiol, your absorption may be impaired
US$ 22.91
US$ 23.55
US$ 28.64
US$ 29.45
US$ 20.00
US$ 22.86
